Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 479-310-7 | CAS number: -
Endpoint summary
Administrative data
Description of key information
The following Acute toxicity studies are available:
Acute Oral toxicity study (rat)
Acute dermal toxicity study (rabbit)
Acute inhalation toxicity (rats)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 5 000 mg/m³
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Additional information
Acute oral (male and female rats), acute dermal (male and female rabbits) and acute inhalation (male and female rats) toxicity studies were performed with Fyrolflex SOL-DP.
Following either oral or dermal administration no mortalities were observed in either sex at 5000 mg/kg, no signs of systemic toxicity were noted during clinical observations and no abnormalities were noted during necropsy.
Following the 4 hours inhalation exposure to 5.23 mg/l aerosol SOL-DP, no exposure related findings were shown in clinical signs of both sexes and only a minor effect on bodyweight profile was noted. Limited necropsy findings were observed in the lungs and mandibular lymph nodes of some animals, and the lung: body weight ratios were considered to be normal.
Justification for classification or non-classification
The above results triggered no classification under the EEC criteria for classification and labelling requirements for Dangerous Substances and Preparations (67/548/EEC) and the CLP Regulation (EC No 1272/2008). Therefore, Fyrolflex SOL-DP is not classified for acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
